Critical issues in the reform of the mining law in the United States

JOM ◽  
1995 ◽  
Vol 47 (4) ◽  
pp. 44-45
Author(s):  
Roderick G. Eggert
1998 ◽  
Vol 07 (04) ◽  
pp. 393-401
Author(s):  
Willam B. Prince

2019 ◽  
Vol 14 (2) ◽  
Author(s):  
Festus E. Obiakor

AbstractOne of the critical issues in education today is how to help all students to maximize their fullest potential. Achieving this goal seems to be difficult for many people who come from culturally and linguistically diverse (CLD) backgrounds. At all levels, they endure direct and indirect disenfranchisements, disadvantages, and disillusionments, especially if they learn differently, are racially different, demonstrate different behavioral patterns, have different personal idiosyncrasies, or come from different countries. Despite these apparent impediments, Asians are viewed by many as “model” minorities when compared to African Americans, Latinos, and Native Americans. This view has continued to affect how Asians view themselves and how the society as a whole views them. Coming originally from Nigeria to the United States, I have had myriad interactions with Asians as student, professor, scholar, leader, and professional. In this article, I share my experiences with Asians and how these experiences have exposed multicultural realities and myths.


2016 ◽  
Vol 32 (4) ◽  
pp. 858-860 ◽  
Author(s):  
James Woodall

Two decades since the World Health Organization Regional Office for Europe published a report on health promotion in prison that stimulated further debate on the concept of the “health-promoting prison,” this article discusses the extent to which the concept has translated to the United States. One predicted indicator of success for the health-promoting prison movement was the expansion of activity beyond European borders; yet 2 decades since the European model was put forward, there has been very limited activity in the United States. This “Critical Issues and Trends” article suggests reasons why this translation has failed to occur.


1970 ◽  
Vol 22 (4) ◽  
pp. 582-596
Author(s):  
Cyril E. Black

The purpose of this paper is to make a preliminary evaluation of the pattern of support of research in international studies in the United States by federal agencies, with a view to identifying critical issues in research policy deserving of more detailed study.The security and welfare of the people of the United States depend to a significant degree on the quality of the system of knowledge available to their leaders and to the community of scholars on whose advice regarding the international system in all of its aspects their leaders depend.


2021 ◽  
Vol 17 (4) ◽  
pp. 32-37
Author(s):  
Tom Fehsenfeld

The purpose of this exploratory study was to develop ideas about the conditions under which the United States Congress can enact forward-looking legislation to address critical issues. The framework for the study is the multiple streams paradigm developed by John Kingdon and modified with insights of subsequent scholars. Conclusions are based on four case studies of significant enactment efforts. Seven propositions about conditions for enactment of forward-looking policies were developed from the cases. Further research is planned to validate the propositions with a larger number of cases.


Author(s):  
Salman Khairi Mohamed ◽  
Eyad Mudhe Gerow

Researchers are increasingly interested in the creative chaos produced by American strategic thinking, especially after the official disclosure by Secretary of State Condoleezza Rice in 2005 that the theory of creative chaos has become a priority of US foreign policy in dealing with critical issues in the Middle East. And Iraq to achieve the goals and interests of the United States and to ensure the need for the requirements of imperial construction without taking into account the material and human costs for the purpose of substantive content reveals the secret link between the religious values on which the American society since His first concern is the American political and strategic orientation, which is characterized by its religious character


Author(s):  
Peter L. Banfe ◽  
Dexter R. Woods

Global electronic commerce, driven by the development of the Internet, promises to be a key engine of growth in this century. One of the most contentious issues facing businesses today is the ownership and use of personal data. Europe has taken the lead in this area with a comprehensive approach, the European Union Data Directive, that became effective in 1998. This paper compares the European Union approach to Internet privacy with that of the United States. In comparing the two, the paper includes a brief discussion of current legislation under both approaches and also discusses critical issues in the debate for Internet privacy, including state-directed legislation vs. self-regulation, corporate privacy statements, and the opt-in versus opt-out approaches to consumer protection. The paper offers perspectives on whether the United States will adopt new Internet privacy legislation, and on the feasibility and repercussions of maintaining the current approach.


2011 ◽  
Vol 9 (8) ◽  
pp. 934-943 ◽  
Author(s):  
Bradford R. Hirsch ◽  
Gary H. Lyman

The introduction of alternative versions of biologic products, also known as biosimilars, into the United States market has been gaining increasing visibility as patents for many agents are nearing expiration. Unlike generics, which are regulated under the Hatch-Waxman legislation passed in 1984, the approval process for biosimilars in the United States has not been defined. In 2004, the European Union established a regulatory pathway for these agents, and the FDA is now following suit. The economic implications are large, with $66.9 billion spent on the top 20 biologics in 2009. Of the top 10 biologics, 6 are routinely used in oncology. As the regulatory requirements are debated, several critical issues must be resolved. The most obvious is that the agents must be shown to be comparable to the original biologic they intend to replace. Knowledge of pharmacokinetic parameters alone will not be adequate, but the amount of clinical data required by the FDA remains unclear. The regulations will define the ease with which a biosimilar can be brought to market, and the associated costs of trials will influence the ultimate price of the medications. Balancing the needs of the relevant stakeholders is critical to ensure patient safety while controlling costs, improving access, and encouraging innovation. This is not an easy balance to strike.


Sign in / Sign up

Export Citation Format

Share Document